Masimo Corporation (MASI)

Market Cap	6.59B
Revenue (ttm)	1.98B
Net Income (ttm)	79.10M
Shares Out	53.09M
EPS (ttm)	1.47
PE Ratio	84.42
Forward PE	34.36
Dividend	n/a
Ex-Dividend Date	n/a

Volume	814,255
Open	120.70
Previous Close	120.61
Day's Range	119.50 - 124.45
52-Week Range	75.22 - 169.58
Beta	0.99
Analysts	Buy
Price Target	148.60 (+19.74%)
Earnings Date	May 7, 2024

About MASI

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Aug 8, 2007
• Employees: 3,800
• Stock Exchange: NASDAQ
• Ticker Symbol: MASI

Financial Performance

In 2023, Masimo's revenue was $2.05 billion, an increase of 0.60% compared to the previous year's $2.04 billion. Earnings were $81.50 million, a decrease of -43.21%.

Analyst Forecast

According to 7 analysts, the average rating for MASI stock is "Buy." The 12-month stock price forecast is $148.6, which is an increase of 19.74% from the latest price.

Price Target

$148.6

(19.74% upside)

Analyst Consensus: Buy